Is this a clue as to the intended future direction of NEU?
"40% of the Loan Funded Shares shall vest when the Company determines to progress NNZ-2591 to a Phase
2b or Phase 3 clinical trial following a positive Phase 2 clinical trial outcome, or executes a partnering
transaction for NNZ-2591"
Kens.
Is this a clue as to the intended future direction of NEU? "40%...
Add NEU (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$21.80 |
Change
0.460(2.16%) |
Mkt cap ! $2.783B | |||
| Open | High | Low | Value | Volume |
| $21.50 | $22.27 | $21.49 | $17.34M | 792.6K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 5 | 3550 | $21.80 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $21.81 | 567 | 1 |
View Market Depth
| Last trade - 16.10pm 16/05/2024 (20 minute delay) ? |
|
|||||
|
Last
$21.85 |
Change
0.460 ( 2.27 %) |
||||
| Open | High | Low | Volume | ||
| $21.56 | $22.26 | $21.50 | 182893 | ||
| Last updated 15.59pm 16/05/2024 ? | |||||
| NEU (ASX) Chart |